comparemela.com

Latest Breaking News On - Freya bidco - Page 1 : comparemela.com

Investegate | Company Announcement

Investegate announcements from Director/PDMR Shareholding

United kingdomMelanie hallPaul sandlandIan pageCompany deferred bonus planCompany global save as you earn planFreya bidcoCompany long term incentive planDechra pharmaceuticalsCash offer of the companySanction hearingTerm incentive planDeferred bonus planGlobal save as you earn planCash offerDeferred bonus

Investegate | Company Announcement

Investegate announcements from Dechra Pharmaceuticals

United kingdomFreya bidcoBaillie gifford us growth trust united kingdomDechra pharmaceuticals united kingdomDechra pharmaceuticalsFreya bidco limited

Investegate | Company Announcement

Investegate announcements from Form 8 (DD) Dechra Pharmaceuticals Plc

United statesRobin greenwoodJefferies internationalRegulatory information serviceDechra pharmaceuticals plcPanel market surveillance unitLeucadia asset managementTakeover codeInternational limitedFinancial advisorFreya bidcoSupplemental formOpen positionsSupplemental formsRegulatory informationMarket surveillance unit

Dechra Pharmaceuticals PLC FY23 Rev GBP761 5M

By Christian Moess Laursen Dechra Pharmaceuticals said it swung to a pretax loss on higher finance costs, but that revenue grew on a strong performance by.

United statesChristian moess laursenFreya bidcoDechra pharmaceuticalsChristian moessNorth americaExecutive ian pageArticle normalHealthcare life sciencesFinancial performanceCorporate industrial newsContent typesFactiva filtersC amp ampe industry news filterDph lnUk dph

Dechra Pharmaceuticals deliver a resilient performance with group revenue growth of 5 5%

Dechra Pharmaceuticals deliver a resilient performance with group revenue growth of 5.5%

United kingdomUnited statesNew zealandNew south walesSaudi arabiaSouth koreaAkston biosciencesIshbel macphersonGeeta gopalanRegulatory affairsInternational pharmaceuticals segmentFreya bidcoCompany dechraAmerican pharmaceuticals segmentEuropean pharmaceuticals segmentFund management

vimarsana © 2020. All Rights Reserved.